¹Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University,Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, P.R. China
²Department of Echocardiagraphy, General Hospital of the Chinese People’s Armed Police Forces, Beijing, P.R. China
³Polymer Research Institute of the Department of Chemical Engineering, Tsinghua University, Beijing, P.R. China
*Corresponding author: Jun-sheng Mu. Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing 100029, China. E-mail: firstname.lastname@example.org
Published: March 25, 2014.
The implantation of the Bone Marrow Mesenchymal Stem Cells (BMSCs) into the heart has been reported to be effective for the treatment of myocardial infarction; however, the methods most suitable for supporting stem cell growth in a myocardial patch, still remain unknown. We used a new polymer material composed of poly(3-hydroxybutyrate-co-3-hydroxybutyrate) [P(3HB-co-3HB)] co-cultured with BMSCs to create a myocardial patch. The BMSCs were obtained from healthy male BSL-C57 mice. The cells were treated with 5-azacytidine to investigate their differentiation into cardiomyocytes. The cells were seeded for 24 hours onto the P(3HB-co-3HB) biological material films (n=8). Cell-biomaterial constructs were fixed and analyzed using different methods. BMSCs were CD34-, CD45-, CD90+ (low) and CD73+. The cells were stained with anti-cardiac troponin T (cTnT) and anti-connexin 43 (CX43) antibodies after 5-azacytidine treatment. Scanning electron microscopy revealed that the morphology of the BMSC was normal and that cell numbers were more abundant on the P(3HB-co-3HB) material surfaces. The growth curve of the BMSCs on the biomaterial patches showed the P(3HB-co-3HB) material enhanced good stem cell growth. Owing to its excellent biocompatibility and biodegradability properties, in particular its porosity, the P(3HB-co-3HB) is hailed as an optimal material to support myocardial cell growth and to create a myocardial patch in patients with myocardial infarction.
- Passier R, van Laake LV, Mummery CL. Stem-cell-based therapy and lessons from the heart. Nature 2008; 453(7193):322–9.
- Dimmeler S, Burchfield J, Zeiher AM. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 2008; 28(2):208-16.
- Menasché P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008; 117(9):1189–200.
- Rosenzweig A. Cardiac cell therapy-mixed results from mixed cells. N Engl J Med 2006; 355(12):1274-7.
- Dow J, Simkhovich BZ, Kedes L, Kloner RA. Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. Cardiovasc Res 2005; 67(2):301-7.
- Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE, et al. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 2001; 33(5):907-21.
- Eschenhagen T, Zimmermann WH. Engineering Myocardial Tissue. Circ Res 2005; 97(12): 1220-31.
- Zhang S, Holmes T, Lockshin C, Rich A. Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. Proc Natl Acad Sci USA 1993; 90(6):3334-8.
- Thornhoff JR, Lou DI, Jordan PM, Zhao X, Wu P. Compatibility of human fetal neural stem cells with hydrogel biomaterials in vitro. Brain Res 2008; 1187:42–51.
- Hamada K, Hirose M, Yamashita T, Ohgushi H. Spatial distribution of mineralized bone matrix produced by marrow mesenchymal stem cells in self-assembling peptide hydrogel scaffold. J Biomed Mater Res 2008; 84(1):128-36.
- Narmoneva DA, Oni O, Sieminski AL, Zhang S, Gertler JP, Kamm RD, et al. Self-assembling short oligopeptides and the promotion of angiogenesis. Biomaterials 2005; 26(23):4837-46.
- Davis ME, Motion JP, Narmoneva DA, Takahashi T, Hakuno D, Kamm RD, et al. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 2005; 111(4):442-50.
- Ellis-Behnke RG, Liang YX, You SW, Tay DK, Zhang S, So KF, et al. Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci USA 2006;103(13):5054-9.
- Zhou Q, Zhou JY, Zheng Z, Zhang H, Hu SS. A novel vascularized patch enhances cell survival and modifies ventricular remodeling in a rat myocardial infarction model. J Thorac Cardiovasc Surg 2010; 140(6):1388-1396. e1-3.
- Valarmathi MT, Goodwin RL, Fuseler JW, Davis JM, Yost MJ, Potts JD. A 3-D cardiac muscle construct for exploring adult marrow stem cell based myocardial regeneration. Biomaterials 2010; 31(12):3185-200.
- Köse GT, Korkusuz F, Korkusuz P, Purali N, Ozkul A, Hasirci V. Bone generation on PHBV matrices: an in vitro study. Biomaterials 2003; 24(27):4999～5007.
- Shachar M, Tsur-Gang O, Dvir T, Leor J, Cohen S. The effect of immobilized RGD peptide in alginate scaffolds on cardiac tissue engineering. Acta Biomater 2011; 7(1):152-62.
- Park BW, Kang EJ, Byun JH, Son MG, Kim HJ, Hah YS, et al. In vitro and in vivo osteogenesis of human mesenchymal stem cells derived from skin, bone marrow and dental follicle tissues. Differentiation 2012; 83(5):249–59.
- Sapir Y, Kryukov O, Cohen S. Integration of multiple cell-matrix interactions into alginate scaffolds for promoting cardiac tissue regeneration. Biomaterials 2011; 32(7):1838-47.
- Saeed H, Taipaleenmäki H, Aldahmash AM, Abdallah BM, Kassem M. Mouse embryonic fibroblasts (MEF) exhibit a similar but not identical phenotype to bone marrow stromal stem cells (BMSC). Stem Cell Rev 2012; 8(2):318-28.
- Zhang S, Ge J, Sun A, Xu D, Qian J, Lin J, et al. Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source. J Cell Biochem 2006; 99(4):1132-47.
- Jain M, Pfister O, Hajjar RJ, Liao R. Mesenchymal stem cells in the infarcted heart. Coron Artery Dis. 2005; 16(2):93-97.
- Martens TP, See F, Schuster MD, Sondermeijer HP, Hefti MM, Zannettino A, et al. .Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium. Nat Clin Pract Cardiovasc Med 2006; 3(1):S18-22.
- Al Kindi AH, Asenjo JF, Ge Y, Chen GY, Bhathena J, Chiu RC, et al. Microencapsulation to reduce mechanical loss of microspheres: implications in myocardial cell therapy. Eur J Cardiothorac Surg 2011; 39(2):241-7.
- Antonitsis P, Ioannidou-Papagiannaki E, Kaidoglou A, Cardiomyogenic potential of human adult bone marrow mesenchymal stem cells in vitro Thorac Cardiovasc Surg 2008; 56(2):77-82.
- Antonitsis P, Ioannidou-Papagiannaki E, Kaidoglou A, Papakonstantinou C. In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azac ytidine. Interact Cardiovasc Thorac Surg 2007; 6(5):593-7.
- Davis ME, Hsieh PC, Grodzinsky AJ, Lee RT. Custom design of the cardiac microenvironment with biomaterials. Circ Res 2005; 97(1):8–15.
- Rando TA, Blau HM. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 1994; 125(6):1275-87.
- Horii A, Wang X, Gelain F, Zhang S. Biological designer self-assembling peptide nanofiber scaffolds significantly enhance osteoblast proliferation, differentiation and 3-D migration. PLoS ONE.2007; 2:190.
- Silva GA, Czeisler C, Niece KL, Beniash E, Harrington DA, Kessler JA, et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 2004; 303(5662):1352-5.
The fully formatted PDF version is available.
Int J Biomed. 2014; 4(1):40-45. © 2014 International Medical Research and Development Corporation. All rights reserved.